High-dose adjuvant interferon therapy for melanoma
- PMID: 9873271
High-dose adjuvant interferon therapy for melanoma
Abstract
High-dose interferon has recently been approved as an adjuvant to surgery for treating newly diagnosed patients at high-risk for melanoma, particularly those with regional lymph node disease. The data supporting the indications for treatment and its side effects are reviewed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical